Esophageal Adenocarcinoma Clinical Trials in Kashiwa
3 recruitingKashiwa, Japan
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
Gastroesophageal Adenocarcinoma
AstraZeneca100 enrolled70 locationsNCT07069712
Recruiting
Phase 2Phase 3
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Bristol-Myers Squibb690 enrolled159 locationsNCT07221149
Recruiting
Phase 1Phase 2
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
Gastric CancerEsophageal AdenocarcinomaPancreatic Ductal Adenocarcinoma+1 more
AstraZeneca280 enrolled25 locationsNCT06005493